STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infection.

Authors:
Sun Q; Zhao X; Li R; Liu D; Pan B and 10 more

Journal:
J Exp Med

Publication Year: 2023

DOI:
10.1084/jem.20220686

PMCID:
PMC9884582

PMID:
36688918

Journal Information

Full Title: J Exp Med

Abbreviation: J Exp Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"figure s1 stat3 is intrinsically critical for the effector function of cd8 + t cells (a) mrna level of stat3 in cd8 + t cells from peripheral blood or tumors in human cancer patients (geo accession nos gse99254 gse108989 and gse98638 ) scrna-seq data of cd8 + t cells in tumors and peripheral blood from lung crc and hcc patients were previously processed and uploaded by others ( http://crc cancer-pku cn/ http://hcc cancer-pku cn/ http://lung cancer-pku cn/ ; ; ; ) and we obtained the stat3 expression values from the above websites.; stat3 -/- ot-i cells transferred into b16-ova-bearing mice ( fig 2 ) are available in the geo database under accession no gse217375 .; stat3 -/- ot-i cells transferred into b16-ova-bearing mice ( fig 6 ) are available in the geo database under accession no gse217372 .; stat3 -/- cd8 + t cells ( fig 6 ) are available in the geo database under accession no gse217374 . data availability data from rna-seq of wt vs. stat3 -/- ot-i cells transferred into b16-ova-bearing mice ( fig 2 ) are available in the geo database under accession no gse217375"

Code Sharing
Evidence found in paper:

"Disclosures: The authors declare no competing interests exist."

Evidence found in paper:

"This work was supported by grants from the Natural Science Foundation of China (31991173, 31821003, and 31991170), the National Key Research and Development Program of China (2021YFC2302403), Tsinghua University Spring Breeze Fund (2020Z99CFG008), Innovative Research Team of High-level Local Universities in Shanghai, Tsinghua University-Xiamen Chang Gung Hospital Joint Research Center for Anaphylactic Disease, and Shanghai Jiao Tong University-Bennu Biotherapeutics Joint Laboratory for Cell Therapy."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025